ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Miami, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pancreatic Cancer
Colorectal Cancer
Stomach Cancer
Non-Small-Cell Lung Carcinoma
Prostatic Cancer
Neoplasm Metastasis
Esophageal Cancer

Adenocarcinoma trials near Miami, FL, USA:

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

with neoadjuvant chemotherapy for the treatment of treatment-naïve subjects with borderline resectable and locally advanced pancreatic ductal adenocarcinoma...

Enrolling
Locally Advanced Pancreatic Adenocarcinoma
Borderline Resectable Pancreatic Adenocarcinoma
Drug: PTM-101

Phase 1

PanTher Therapeutics

Miami, Florida, United States and 8 other locations

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard of care (SOC) observation only.

Enrolling
Resected Pancreatic Adenocarcinoma
PDAC - Pancreatic Ductal Adenocarcinoma
Drug: daraxonrasib

Phase 3

Revolution Medicines
Revolution Medicines

Miami, Florida, United States and 85 other locations

The purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compared with SOC GnP alone.

Enrolling
Pancreatic Adenocarcinoma Metastatic
PDAC - Pancreatic Ductal Adenocarcinoma
Drug: mGnP
Drug: GnP

Phase 3

Immuneering Corporation

Miami, Florida, United States and 71 other locations

The purpose of this study is to understand whether a blood-based test called circulating tumor DNA (ctDNA) can detect whether participants are having...

Enrolling
Metastatic Pancreatic Ductal Adenocarcinoma
Pancreatic Ductal Adenocarcinoma
Diagnostic Test: Circulating Tumor Deoxyribonucleic acid (ctDNA) Assay
Drug: 5-Fluorouracil

Phase 2

University of Miami
University of Miami

Miami, Florida, United States

The purpose of this research study is to see the effects (good or bad) of Lorigerlimab on patients with pancreatic adenocarcinoma (PDAC) and...

Begins enrollment in 1 month
Pancreatic Adenocarcinoma
Homologous Recombination Deficiency
Drug: Lorigerlimab

Phase 2

University of Miami
University of Miami

Miami, Florida, United States

The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitab...

Active, not recruiting
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 3

Arcus Biosciences
Arcus Biosciences

Miami, Florida, United States and 118 other locations

The purpose of this study is to test any good and bad effects of the study drug called PEGPH20. PEGPH20 alone is considered investigational. The Food...

Active, not recruiting
Advanced Pancreatic Ductal Adenocarcinoma
Pancreatic Cancer
Drug: Nab-paclitaxel
Drug: Gemcitabine
Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Miami, Florida, United States and 9 other locations

This study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer,...

Enrolling
Pancreatic Adenocarcinoma
Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Drug: ASP546C

Phase 1, Phase 2

Astellas
Astellas

Miami, Florida, United States and 21 other locations

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment.

Active, not recruiting
PDAC - Pancreatic Ductal Adenocarcinoma
PDAC
Drug: 5-fluorouracil
Drug: leucovorin

Phase 3

Revolution Medicines
Revolution Medicines

Miami, Florida, United States and 59 other locations

in individuals with pathologically confirmed pancreatic ductal adenocarcinoma. Following screening, using a standardized administration prot...

Enrolling
Pancreatic Ductal Adenocarcinoma (PDAC)
Drug: [18F]FAPI-74 PET/CT

Phase 3

SOFIE

Coral Springs, Florida, United States and 18 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems